embelin has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burstein, D; Che, Y; Cui, M; Jiang, B; Qing, H; Wang, X; Xu, R; Ye, F; Yin, F; Zhang, DY | 1 |
| Ahn, KS; Bae, H; Choi, SH; Kim, SH; Kim, SM; Kim, SW; Lee, JH; Lee, SG; Nam, D; Sethi, G; Shim, BS | 1 |
2 other study(ies) available for embelin and cyclin d1
| Article | Year |
|---|---|
Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Topics: Aged; Apoptosis; Benzoquinones; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Phosphorylation; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2012 |
Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
Topics: Androgens; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Humans; In Vitro Techniques; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases | 2013 |